ChronoScale Corporation Common Stock (NASDAQ:CHRN) Trading 6.6% Higher – Time to Buy?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s stock price was up 6.6% during trading on Wednesday . The stock traded as high as $18.87 and last traded at $18.83. Approximately 39,104 shares were traded during trading, a decline of 84% from the average session volume of 243,492 shares. The stock had previously closed at $17.66.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus target price of $6.00.

ChronoScale Corporation Common Stock Stock Up 6.9%

The company has a market capitalization of $2.75 billion, a price-to-earnings ratio of -3.51 and a beta of 1.00. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.06. The business has a 50-day moving average price of $21.60 and a 200-day moving average price of $16.31.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share for the quarter. The company had revenue of $18.40 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. As a group, equities analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Virtu Financial LLC purchased a new stake in ChronoScale Corporation Common Stock in the 3rd quarter worth about $57,000. Citadel Advisors LLC purchased a new position in ChronoScale Corporation Common Stock during the 3rd quarter valued at about $198,000. Geode Capital Management LLC grew its stake in ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after acquiring an additional 10,281 shares in the last quarter. Shay Capital LLC acquired a new position in shares of ChronoScale Corporation Common Stock in the 3rd quarter valued at about $67,000. Finally, Roble Belko & Company Inc increased its holdings in shares of ChronoScale Corporation Common Stock by 104.5% in the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after purchasing an additional 1,195 shares during the period. Hedge funds and other institutional investors own 6.42% of the company’s stock.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.